HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 61 filers reported holding HOMOLOGY MEDICINES INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,044,378 | -21.7% | 1,622,522 | 0.0% | 0.03% | -27.0% |
| Q3 2022 | $2,612,000 | -18.3% | 1,622,522 | 0.0% | 0.04% | -17.8% |
| Q2 2022 | $3,196,000 | -36.2% | 1,622,522 | -1.5% | 0.04% | -22.4% |
| Q1 2022 | $5,007,000 | -20.8% | 1,647,122 | -5.2% | 0.06% | -10.8% |
| Q4 2021 | $6,323,000 | -53.7% | 1,737,122 | 0.0% | 0.06% | -53.2% |
| Q3 2021 | $13,671,000 | +8.3% | 1,737,122 | 0.0% | 0.14% | +13.0% |
| Q2 2021 | $12,629,000 | -22.7% | 1,737,122 | 0.0% | 0.12% | -28.9% |
| Q1 2021 | $16,346,000 | -16.7% | 1,737,122 | 0.0% | 0.17% | -23.1% |
| Q4 2020 | $19,612,000 | +5.5% | 1,737,122 | 0.0% | 0.22% | -12.5% |
| Q3 2020 | $18,587,000 | -29.6% | 1,737,122 | 0.0% | 0.26% | -31.1% |
| Q2 2020 | $26,387,000 | +5.3% | 1,737,122 | +7.8% | 0.37% | -23.3% |
| Q1 2020 | $25,052,000 | -24.9% | 1,612,122 | 0.0% | 0.49% | -8.1% |
| Q4 2019 | $33,371,000 | +14.4% | 1,612,122 | 0.0% | 0.53% | -2.6% |
| Q3 2019 | $29,179,000 | +6.3% | 1,612,122 | +15.0% | 0.54% | +15.8% |
| Q2 2019 | $27,440,000 | – | 1,402,122 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $5,307,025 | 1.53% |
| Western Standard LLC | 250,060 | $292,570 | 0.26% |
| OUP Management Co., LLC | 64,000 | $74,880 | 0.17% |
| Vivo Capital, LLC | 370,068 | $432,980 | 0.05% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $6,611,665 | 0.04% |
| GEORGE KAISER FAMILY FOUNDATION | 39,320 | $46,004 | 0.01% |
| American Investment Services, Inc. | 36,955 | $43,238 | 0.01% |
| RBF Capital, LLC | 58,700 | $68,679 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 185,100 | $216,567 | 0.01% |
| XTX Topco Ltd | 21,188 | $24,790 | 0.00% |